Congress funds open-access biotech labs to compete with China, boost rural jobs
H.R. 8918 — BIO-SCALE Act · Filed by James Baird (R-IN) · 1 cosponsor · Introduced May 20, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Commerce to establish at least 3 regional, nonprofit, open-access facilities where companies and researchers can test and scale up bioindustrial technologies—converting agricultural waste, algae, and other feedstocks into chemicals, fuels, and materials. The facilities will offer shared fermentation equipment and infrastructure on an equitable basis to both public and private entities, with $345 million authorized for 2026–2028 and $117 million for 2029–2030. The goal is to position the U.S. as a leader in biotechnology innovation and create jobs, especially in rural areas.
Why we flagged it
The bill establishes federally funded, nonprofit, open-access shared facilities for bioindustrial R&D and scale-up. This is a classic public-goods investment model—reducing private capital barriers and spreading innovation benefits across the sector rather than concentrating them in one firm or narrow group.
What the text implies
- Facilities will operate under a 10-year sunset clause, but successful ones may continue indefinitely at Secretary's discretion—creating ongoing operational uncertainty and potential for political influence over which facilities survive.
- Intellectual property created by non-federal employees is protected under 'applicable IP laws' and 'terms of agreement with the Secretary'—the bill does not specify those terms, leaving room for future restrictions on commercialization rights or data access.
The full analysis lists 4 implications of this text.
Who stands to gain
nonprofit organizations and universities (planning and implementation grants); bioindustrial companies (access to shared infrastructure at subsidized cost); construction and equipment vendors (facility buildout contracts)